EPC0387	Temporal change of PrEP use and adherence in MSM: pill fatigue or COVID-19 effect?	E-poster	HIV prevention research
LBEPB20	T-cell responses induced by HTI vaccines and vesatolimod correlate with improved control of HIV rebound	E-poster	Other strategies and therapies
EPA0088	TB-associated microenvironment represents a barrier for HIV curative strategies	E-poster	HIV-associated viruses, co-infections and co-morbidities
EPA0076	Tat diversity in intact versus defective proviral HIV-1 DNA genomes across viral subtypes	E-poster	Understanding and targeting persistent HIV reservoirs
EPD0642	Tailoring innovative legal solutions for key populations to prevailing conditions of criminalisation and active politicisation: a case study of Human Rights Awareness and Promotion Forum - Uganda	E-poster	Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts
OAE0502	Tackling health facility intersectional stigma faced by men who have same-gender sex in Ghana: early results from a randomized control trial	Oral abstract session with live Q&A	Health systems, health systems strengthening and partnerships
EPC0441	Systematic review of the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) initiative among adolescent girls and young women	E-poster	Population-specific interventions for HIV prevention
EPE0872	Systematic review of person-centred care interventions for persons living with HIV in low and middle-income countries	E-poster	Implementation science and scale up of treatment
EPA0075	Synergistic effects of romidepsin with PI3K inhibitors in reducing the pool of HIV latently infected cells ex vivo	E-poster	Understanding and targeting persistent HIV reservoirs
EPB0218	Switching to dolutegravir/lamivudine (DTG/3TC) is non-inferior to continuing tenofovir alafenamide (TAF)-based regimens at Week 196: TANGO subgroup analyses	E-poster	Antiretroviral therapies and clinical issues in adults